PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31300540-9	2019	Dinaciclib-induced HR disruption was also observed in human prostate cells with knockdown of MAP3K7.	dinaciclib	0-10	mitogen-activated protein kinase kinase kinase 7	Homo sapiens	93-99	
31300540-10	2019	Cotreatment of dinaciclib with DNA-damaging agents or PARP inhibitor resulted in a stronger cytotoxic effect on prostate cells with suppression of MAP3K7 compared with those without loss of MAP3K7, or to each single agent.	dinaciclib	15-25	mitogen-activated protein kinase kinase kinase 7	Homo sapiens	147-153	
31300540-10	2019	Cotreatment of dinaciclib with DNA-damaging agents or PARP inhibitor resulted in a stronger cytotoxic effect on prostate cells with suppression of MAP3K7 compared with those without loss of MAP3K7, or to each single agent.	dinaciclib	15-25	mitogen-activated protein kinase kinase kinase 7	Homo sapiens	190-196